Diagnosis and Management in Psychiatry: A New Era

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (20 April 2023) | Viewed by 2405

Special Issue Editor


E-Mail Website
Guest Editor
Department of Psychiatry, Tehran University of Medical Sciences, Roozbeh Hospital, Tehran, Iran
Interests: child psychiatry; mental illness; psychology of adolescence; developmental psychopathology; child development; psychopathology; psychoeducation; psychological assessment

Special Issue Information

Dear Colleagues, 

Psychiatry as a medical discipline deals primarily with the diagnosis and management of mental disorders. However, the concept of mental disorder and how to define and approach it clinically has been the subject of debate for many decades. Classification of psychiatric disorders is one of the key debates, given the shortcomings of our two main classification systems of DSM and ICD. Dimensional classifications such as RDoC, among others, along with more sophisticated statistical approaches toward classification represent the recent attempts to address some of the challenges in working with older classification systems, while considering developmental trajectories and environmental influences. In terms of treatment and service development, clinical neuroscience, personalized pharmacotherapy, interventional psychiatry technologies (such as rTMS protocols), more targeted evidence-based psychotherapy, community mental health care, digital phenotyping and therapies and task sharing approaches have all contributed to a new era of diagnosis and treatment in psychiatry. In this Special Issue, we invite all relevant investigators to help us shed light on different aspects of the current status and future directions of diagnosis and treatment in psychiatry.

Dr. Javad Alaghband-rad
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • personalized pharmacotherapy
  • community mental health care
  • evidence-based psychotherapy
  • interventional psychiatry
  • DSM
  • ICD
  • RDoC
  • developmental psychopathology
  • neurodevelopmental disorders
  • psychiatric classification
  • clinical neuroscience

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

11 pages, 534 KiB  
Review
How to Make the Unpredictable Foreseeable? Effective Forms of Assistance for Children with Autism Spectrum Disorder (ASD) during the COVID-19 Pandemic
by Jagoda Grzejszczak, Agata Gabryelska, Agnieszka Gmitrowicz and Dominik Strzelecki
Diagnostics 2023, 13(3), 407; https://doi.org/10.3390/diagnostics13030407 - 22 Jan 2023
Viewed by 2097
Abstract
Symptomatology in patients with the diagnosis of autism spectrum disorder (ASD) is very heterogeneous. The symptoms they present include communication difficulties, behavior problems, upbringing problems from their parents, and comorbidities (e.g., epilepsy, intellectual disability). A predictable and stable environment and the continuity of [...] Read more.
Symptomatology in patients with the diagnosis of autism spectrum disorder (ASD) is very heterogeneous. The symptoms they present include communication difficulties, behavior problems, upbringing problems from their parents, and comorbidities (e.g., epilepsy, intellectual disability). A predictable and stable environment and the continuity of therapeutic interactions are crucial in this population. The COVID-19 pandemic has created much concern, and the need for home isolation to limit the spread of the virus has disrupted the functioning routine of children/adolescents with ASD. Are there effective diagnostic and therapeutic alternatives to limit the consequences of disturbing the daily routine of young patients during the unpredictable times of the pandemic? Modern technology and telemedicine have come to the rescue. This narrative review aims to present a change in the impact profile in the era of isolation and assess the directions of changes that specialists may choose when dealing with patients with ASD. Full article
(This article belongs to the Special Issue Diagnosis and Management in Psychiatry: A New Era)
Show Figures

Figure 1

Back to TopTop